Arthritis
Welcome,         Profile    Billing    Logout  
 248 Companies   339 Products   339 Products   149 Mechanisms of Action   22 Trials   5600 News 


12345678910111213...109110»
  • ||||||||||  Inflectra (infliximab-dyyb) / Alvogen, Celltrion, Mundipharma, Egis, Nippon Kayaku, Pfizer
    Enrollment change, Trial termination:  An Observational Study to Evaluate Safety and Efficacy of Remsima (clinicaltrials.gov) -  Feb 15, 2024   
    P=N/A,  N=248, Terminated, 
    Active, not recruiting --> Terminated; Incomplete student research project N=950 --> 248 | Recruiting --> Terminated; Terminated
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Trial completion date, Trial primary completion date:  Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot Study (clinicaltrials.gov) -  May 1, 2019   
    P=N/A,  N=31, Completed, 
    Trial primary completion date: Oct 2020 --> Dec 2023 Active, not recruiting --> Completed | Trial completion date: Sep 2017 --> Jul 2018 | Trial primary completion date: Sep 2017 --> Jul 2018
  • ||||||||||  Trial completion:  PRISM: Pictorial Representation of Illness and Self Measure (clinicaltrials.gov) -  Apr 30, 2019   
    P=N/A,  N=220, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Sep 2017 --> Jul 2018 | Trial primary completion date: Sep 2017 --> Jul 2018 Active, not recruiting --> Completed
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  Implantology and Sj (clinicaltrials.gov) -  Apr 30, 2019   
    P=N/A,  N=120, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed
  • ||||||||||  NN1213 / Novo Nordisk
    Enrollment change, Trial completion date, Trial termination, Trial primary completion date:  REMINDRA: REMission INDuction in Very Early Rheumatoid Arthritis (clinicaltrials.gov) -  Apr 29, 2019   
    P4,  N=53, Terminated, 
    Recruiting --> Completed N=267 --> 53 | Trial completion date: Nov 2023 --> Jan 2019 | Recruiting --> Terminated | Trial primary completion date: Nov 2022 --> Jan 2019; low recruitment rate
  • ||||||||||  Trial completion:  Femoral Remodeling Following Total Hip Arthroplasty With OMNI Apex Modular (clinicaltrials.gov) -  Apr 26, 2019   
    P=N/A,  N=73, Completed, 
    N=267 --> 53 | Trial completion date: Nov 2023 --> Jan 2019 | Recruiting --> Terminated | Trial primary completion date: Nov 2022 --> Jan 2019; low recruitment rate Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  A Study of Flt3-Ligand Levels in Sj (clinicaltrials.gov) -  Apr 24, 2019   
    P=N/A,  N=30, Completed, 
    Active, not recruiting --> Completed | N=79 --> 200 Recruiting --> Completed | N=50 --> 30 | Trial completion date: Dec 2019 --> Apr 2019 | Trial primary completion date: Dec 2019 --> Apr 2019
  • ||||||||||  Enrollment change, Trial completion date, Trial termination, Trial primary completion date:  Outcomes Study of the TM Humeral Stem Used in Primary, Total or Hemi Shoulder Arthroplasty (clinicaltrials.gov) -  Apr 20, 2019   
    P=N/A,  N=67, Terminated, 
    Recruiting --> Completed | N=50 --> 30 | Trial completion date: Dec 2019 --> Apr 2019 | Trial primary completion date: Dec 2019 --> Apr 2019 N=120 --> 67 | Trial completion date: Dec 2024 --> Dec 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2023 --> Dec 2018; Business decision was made to remove the CE mark from this product, thus prompting the closing of this study.
  • ||||||||||  Trial completion, Trial completion date:  10003 PRO Current Products (clinicaltrials.gov) -  Apr 20, 2019   
    P=N/A,  N=842, Completed, 
    N=120 --> 67 | Trial completion date: Dec 2024 --> Dec 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2023 --> Dec 2018; Business decision was made to remove the CE mark from this product, thus prompting the closing of this study. Active, not recruiting --> Completed | Trial completion date: Mar 2019 --> Aug 2018
  • ||||||||||  Enrollment change, Trial completion date, Trial termination, Trial primary completion date:  Resistance Exercise in Rheumatic Disease (clinicaltrials.gov) -  Apr 20, 2019   
    P=N/A,  N=15, Terminated, 
    Active, not recruiting --> Completed | Trial completion date: Mar 2019 --> Aug 2018 N=10 --> 15 | Trial completion date: Jun 2019 --> Dec 2018 | Suspended --> Terminated | Trial primary completion date: Jun 2019 --> Dec 2018; Funding ended.
  • ||||||||||  NN1213 / Novo Nordisk
    Biomarker, Trial completion:  Salivary Biomarkers for Sj (clinicaltrials.gov) -  Apr 20, 2019   
    P=N/A,  N=420, Completed, 
    N=20 --> 4 | Enrolling by invitation --> Terminated; no available participants Active, not recruiting --> Completed
  • ||||||||||  NN1213 / Novo Nordisk
    Enrollment change, Trial completion date, Trial termination, Trial primary completion date:  PRESSRA: The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis (clinicaltrials.gov) -  Apr 19, 2019   
    P=N/A,  N=23, Terminated, 
    Active, not recruiting --> Completed N=50 --> 23 | Trial completion date: Dec 2018 --> Jul 2018 | Suspended --> Terminated | Trial primary completion date: Dec 2018 --> Jul 2018; Funding ended
  • ||||||||||  NN1213 / Novo Nordisk
    Enrollment change, Trial termination:  Massage Therapy in Juvenile Idiopathic Arthritis (clinicaltrials.gov) -  Apr 19, 2019   
    P=N/A,  N=6, Terminated, 
    N=50 --> 23 | Trial completion date: Dec 2018 --> Jul 2018 | Suspended --> Terminated | Trial primary completion date: Dec 2018 --> Jul 2018; Funding ended N=30 --> 6 | Recruiting --> Terminated; Inability to recruit study participants
  • ||||||||||  Enrollment change, Trial completion date, Trial initiation date, Trial withdrawal, Trial primary completion date, Surgery:  Comparison of Implant Positioning With Robotic Aided Surgery and Traditional Jig Positioning in Total Knee Arthroplasty (clinicaltrials.gov) -  Apr 4, 2019   
    P=N/A,  N=0, Withdrawn, 
    Recruiting --> Terminated N=200 --> 0 | Trial completion date: Mar 2019 --> Dec 2019 | Initiation date: Jun 2017 --> Jul 2018 | Not yet recruiting --> Withdrawn | Trial primary completion date: Mar 2018 --> Jul 2019
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Enrollment change, Trial primary completion date, Surgery:  Out Patient Surgery for Total Knee and Hip Replacement and Unicompartmental Knee Replacement - a Feasibility Study (clinicaltrials.gov) -  Mar 28, 2019   
    P=N/A,  N=1000, Completed, 
    Trial completion date: Dec 2019 --> Feb 2019 | Recruiting --> Terminated | Trial primary completion date: Dec 2019 --> Feb 2019; Lack of trial population, unable to recruit subjects Recruiting --> Completed | N=1500 --> 1000 | Trial primary completion date: Aug 2017 --> Aug 2018
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  Ambulation Versus Standing on Postoperative Day 0 (clinicaltrials.gov) -  Mar 28, 2019   
    P=N/A,  N=394, Completed, 
    Recruiting --> Completed | N=1500 --> 1000 | Trial primary completion date: Aug 2017 --> Aug 2018 Active, not recruiting --> Completed
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Trial primary completion date:  Closed Suction Drainage in Shoulder Arthroplasty (clinicaltrials.gov) -  Mar 27, 2019   
    P=N/A,  N=100, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Dec 2017 --> Jan 2019
  • ||||||||||  Saxenda (liraglutide 3 mg) / Novo Nordisk
    Biomarker, Trial completion, Trial completion date:  BIO-LOSEIT-II: Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Maintenance (clinicaltrials.gov) -  Mar 25, 2019   
    P4,  N=150, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Jun 2019 --> Mar 2019 Active, not recruiting --> Completed | Trial completion date: Jun 2019 --> Mar 2019
  • ||||||||||  Saxenda (liraglutide 3 mg) / Novo Nordisk
    Trial completion, Trial completion date:  LOSEIT: Liraglutide 3 mg for Knee Osteoarthritis (clinicaltrials.gov) -  Mar 25, 2019   
    P4,  N=150, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Jun 2019 --> Mar 2019 Active, not recruiting --> Completed | Trial completion date: Jun 2019 --> Mar 2019
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Trial completion date, Trial primary completion date:  GRIP: Safety and Effectiveness of Cartiva Implant in the Treatment of First CMC Joint Osteoarthritis (clinicaltrials.gov) -  Mar 22, 2019   
    P=N/A,  N=50, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Jun 2019 --> Mar 2019 Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Mar 2019 | Trial primary completion date: Dec 2018 --> Mar 2019
  • ||||||||||  Simponi (golimumab) / J&J
    Enrollment change, Trial completion date, Trial termination, Trial primary completion date:  Go-Thermal: Thermography in Assessing Treatment Response to Golimumab in Psoriatic Arthritis (clinicaltrials.gov) -  Mar 22, 2019   
    P=N/A,  N=4, Terminated, 
    Trial completion date: Jan 2018 --> Apr 2018 | Trial primary completion date: Jan 2018 --> Apr 2018 N=10 --> 4 | Trial completion date: Jun 2017 --> Sep 2017 | Recruiting --> Terminated | Trial primary completion date: Jun 2017 --> Sep 2017; The study was stopped due to resourcing issues.
  • ||||||||||  eszopiclone / Generic mfg.
    Enrollment change:  Insomnia and Osteoarthritis Study (clinicaltrials.gov) -  Mar 14, 2019   
    P=N/A,  N=30, Completed, 
    N=10 --> 4 | Trial completion date: Jun 2017 --> Sep 2017 | Recruiting --> Terminated | Trial primary completion date: Jun 2017 --> Sep 2017; The study was stopped due to resourcing issues. N=105 --> 30